PepGen Inc. (PEPG)
2.52
-0.18
(-6.67%)
USD |
NASDAQ |
Oct 23, 16:00
2.53
+0.01
(+0.40%)
After-Hours: 20:00
PepGen EPS Diluted (Quarterly) : -0.2574 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2574 |
| March 31, 2026 | -0.2571 |
| December 31, 2025 | -0.2666 |
| September 30, 2025 | -0.5246 |
| June 30, 2025 | -0.705 |
| March 31, 2025 | -0.9243 |
| December 31, 2024 | -0.6822 |
| September 30, 2024 | -0.6563 |
| June 30, 2024 | -0.8727 |
| March 31, 2024 | -0.6288 |
| December 31, 2023 | -0.8185 |
| September 30, 2023 | -0.979 |
| Date | Value |
|---|---|
| June 30, 2023 | -0.8206 |
| March 31, 2023 | -0.6868 |
| December 31, 2022 | -0.6299 |
| September 30, 2022 | -0.7897 |
| June 30, 2022 | -1.229 |
| March 31, 2022 | -18.94 |
| December 31, 2021 | -0.319 |
| September 30, 2021 | -0.3623 |
| March 31, 2021 | -0.2963 |
| December 31, 2020 | -0.1333 |
| September 30, 2020 | -0.015 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.81M |
| Total Expenses (Quarterly) | 17.81M |
| Enterprise Value | 73.39M |
| Earnings Yield | -51.81% |
| Normalized Earnings Yield | -51.81 |